<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Case Reports Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Case Reports Immunol</journal-id><journal-id journal-id-type="publisher-id">CRII</journal-id><journal-title-group><journal-title>Case Reports in Immunology</journal-title></journal-title-group><issn pub-type="ppub">2090-6609</issn><issn pub-type="epub">2090-6617</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25374736</article-id><article-id pub-id-type="pmc">4207491</article-id><article-id pub-id-type="doi">10.1155/2013/231565</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Scalp Necrosis as a Late Sign of Giant-Cell Arteritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alimohammadi</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Knight</surname><given-names>Ann</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Medical Sciences, Uppsala University, Sweden</aff><aff id="I2"><sup>2</sup>Unit of Dermatology, Rheumatology, and Hematology, Uppsala University Hospital, 75185 Uppsala, Sweden</aff><author-notes><corresp id="cor1">*Mohammad Alimohammadi: <email>mohammad.alimohammadi@medsci.uu.se</email></corresp><fn fn-type="other"><p>Academic Editors: A. M. Mansour and P. Szodoray</p></fn></author-notes><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>9</day><month>1</month><year>2013</year></pub-date><volume>2013</volume><elocation-id>231565</elocation-id><history><date date-type="received"><day>20</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>11</day><month>12</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 M. Alimohammadi and A. Knight.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Retinal infarction and scalp necrosis are described as unusual but devastating complications of giant-cell arteritis. We report a patient with this rare complication and emphasize the importance of timely diagnosis and treatment of giant-cell arteritis.</p></abstract></article-meta></front><body><p>A previously healthy 70-year-old smoking female presented with 10-day history of loss of vision and scalp-tenderness. The event was diagnosed as amaurosis fugax. Fundoscopy indicated a pale oedematous papilla and a temporal peripapillary lozenge-shaped whitish patch on the retina, indicating optic nerve and cilioretinal artery infarction (<xref ref-type="fig" rid="fig1">Figure 1(a)</xref>). Her ESR was 69&#x02009;mm. Giant-cell arteritis (GCA) was suspected and treatment with prednisolone 60&#x02009;mg daily was initiated. However, a biopsy from the left temporal artery could not confirm the diagnosis and due to a left carotid murmur an ultrasound was performed which revealed a significant carotid stenosis.</p><p>An endarterectomy was performed and prednisolone was withdrawn postoperatively as the carotid stenosis was assessed as the cause of patient's symptoms. Within the following two months the patient's vision deteriorated and she developed a bilateral scalp necrosis (<xref ref-type="fig" rid="fig1">Figure 1(b)</xref>). A second temporal biopsy confirmed the diagnosis of GCA and prednisolone treatment was restarted. </p><p>GCA is a chronic granulomatous vasculitis of unknown etiology. The prevalence of the disease increase with age. The diagnosis of CGA can be based on clinical findings such as headache, scalp tenderness, jaw claudication, temporal artery abnormalities, elevated erythrocyte sedimentation rate, and biopsy of temporal artery showing granulomatous process [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. </p><p>Retinal infarction and scalp necrosis are described as unusual but devastating complications to inadequately treated GCA. The present case illustrates that the vasculitis in GCA can affect several extracranial arteries resulting in cilioretinal artery and disc infarction as well as scalp necrosis (<xref ref-type="fig" rid="fig1">Figure 1(c)</xref>) [<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B5" ref-type="bibr">5</xref>]. The case also highlights importance of timely diagnosis and treatment of GCA. </p><p>Cilioretinal artery and disc infarction can occur in the context of carotid disease [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>]. Both giant-cell arteritis and carotid disease can coexist in the same patient and yield some clinical confusion. Even though scalp necrosis due to giant-cell arteritis is rare with around a hundred cases reported, a high level of suspicion must be held for this cutaneous sign in order to initiate prompt therapy to avoid blindness.</p></body><back><sec><title>Consent</title><p>The patient has signed an informed consent form.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunder</surname><given-names>GG</given-names></name></person-group><article-title>The early history of giant cell arteritis and polymyalgia rheumatica: first descriptions to 1970</article-title><source><italic>Mayo Clinic Proceedings</italic></source><year>2006</year><volume>81</volume><issue>8</issue><fpage>1071</fpage><lpage>1083</lpage><pub-id pub-id-type="other">2-s2.0-33746794966</pub-id><pub-id pub-id-type="pmid">16901030</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantini</surname><given-names>F</given-names></name><name><surname>Niccoli</surname><given-names>L</given-names></name><name><surname>Nannini</surname><given-names>C</given-names></name><name><surname>Bertoni</surname><given-names>M</given-names></name><name><surname>Salvarani</surname><given-names>C</given-names></name></person-group><article-title>Diagnosis and treatment of giant cell arteritis</article-title><source><italic>Drugs and Aging</italic></source><year>2008</year><volume>25</volume><issue>4</issue><fpage>281</fpage><lpage>297</lpage><pub-id pub-id-type="other">2-s2.0-41149143541</pub-id><pub-id pub-id-type="pmid">18361539</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaffar</surname><given-names>SA</given-names></name><name><surname>Todd</surname><given-names>PM</given-names></name></person-group><article-title>Scalp necrosis secondary to giant-cell arteritis</article-title><source><italic>Clinical and Experimental Dermatology</italic></source><year>2010</year><volume>35</volume><issue>3</issue><fpage>e40</fpage><lpage>e41</lpage><pub-id pub-id-type="other">2-s2.0-77749328247</pub-id><pub-id pub-id-type="pmid">20500172</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>D</given-names></name></person-group><article-title>Ocular ichemia syndrome&#x02014;a malignant course of giant cell arteritis</article-title><source><italic>European Journal of Medical Research</italic></source><year>2005</year><volume>10</volume><issue>6</issue><fpage>233</fpage><lpage>242</lpage><pub-id pub-id-type="other">2-s2.0-21344449065</pub-id><pub-id pub-id-type="pmid">16033712</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayreh</surname><given-names>SS</given-names></name></person-group><article-title>Acute retinal arterial occlusive disorders</article-title><source><italic>Progress in Retinal and Eye Research</italic></source><year>2011</year><volume>30</volume><issue>5</issue><fpage>359</fpage><lpage>394</lpage><pub-id pub-id-type="other">2-s2.0-79960170649</pub-id><pub-id pub-id-type="pmid">21620994</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>CGA-associated retinal infarction and scalp necrosis&#x02014;illustration of the underlying pathomechanism. Fundoscopy indicated a pale oedematous papilla and a patch on the retina, indicating optic nerve and retinal infarction (a). Clinical photographs of the patient upon withdrawal of prednisolone (b). Illustration of the branches of external carotid artery supplying retina and the scalp (c). </p></caption><graphic xlink:href="CRII2013-231565.001"/></fig></floats-group></article>